ST, H., L, B., AL, K., SB, W., D, L., & AM, B. (2026). Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity. Arteriosclerosis, thrombosis, and vascular biology, 46(6), e319865. https://doi.org/10.1161/ATVBAHA.125.319865
Chicago Style (17th ed.) CitationST, Hammond, Brandt L, Kong AL, White SB, Lewandowski D, and Beyer AM. "Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity." Arteriosclerosis, Thrombosis, and Vascular Biology 46, no. 6 (2026): e319865. https://doi.org/10.1161/ATVBAHA.125.319865.
MLA (9th ed.) CitationST, Hammond, et al. "Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 46, no. 6, 2026, p. e319865, https://doi.org/10.1161/ATVBAHA.125.319865.